Orion Market Research Pvt. Ltd. info@omrglobal.com +91 780-304-0404
Help Center
Careers
Contact

Esomeprazole Market

Esomeprazole Market Size, Share & Trends Analysis Report, By Product Type (Tablets, Capsules, Injectable (IV formulations), Oral Suspension / Sachets), By Application (Gastroesophageal Reflux Disease (GERD), Peptic Ulcer Disease, Zollinger–Ellison Syndrome, Helicobacter pylori Eradication (Combination Therapy), NSAID-induced Ulcers, Others (Acid-related disorders)), By Manufacturing Type (In-house Manufacturing, Contract Manufacturing (CMO/CDMO)), Forecast Period (2026-2035)

Published: May 2026 | Report Code: OMR2029583 | Category : Pharmaceuticals | Delivery Format: /

Industry Overview

Esomeprazole market size was valued at $2.01 billion in 2025 and is projected to reach $3.62 billion by 2035, growing at a CAGR of 6.05% between 2026 and 2035. The market comprises proton pump inhibitors (PPIs) used for the treatment of acid-related gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and NSAID-induced ulcers. A key driver supporting market growth is the increasing prevalence of gastrointestinal diseases globally. According to the World Health Organization, digestive disorders remain among the most common health conditions worldwide, significantly affecting millions of individuals. Additionally, the U.S. Food and Drug Administration highlights that prolonged NSAID use is a major cause of gastric ulcers, increasing demand for protective therapies such as esomeprazole. Increasing healthcare access, rising awareness, and the availability of generic formulations are further driving market growth across hospitals, clinics, and homecare settings.

Market Dynamics

Rising Global Gastrointestinal Disease Burden Driving Market Growth

The rising prevalence of gastrointestinal disorders is a major factor driving the esomeprazole market. According to the World Health Organization, GERD and ulcer-related conditions affect a significant portion of the global population. Increasing use of NSAIDs for chronic pain management is further contributing to gastric complications. Additionally, the Organisation for Economic Co-operation and Development reports rising healthcare spending globally, improving access to pharmaceutical treatments. Pharmaceutical companies are expanding generic drug portfolios and enhancing distribution networks between 2025 and 2026 to capture growing demand in emerging markets.

Generic Competition and Pricing Pressure Limiting Market Growth

Despite strong demand, the esomeprazole market faces challenges due to increasing generic competition and pricing pressure. Patent expirations have led to a significant rise in generic drug availability, reducing profit margins for branded drugs. According to the European Federation of Pharmaceutical Industries and Associations, the generics market is expanding rapidly, intensifying competition. Additionally, regulatory requirements and manufacturing costs create barriers to entry. Supply chain disruptions and raw material cost fluctuations further impact production efficiency. Companies are focusing on cost optimization, contract manufacturing, and differentiated product strategies to address these challenges.

Market Segmentation

  • Based on the product type, the market is segmented into tablets, capsules, injectable (iv formulations), and oral suspension / sachets.
  • Based on the application, the market is segmented into gastroesophageal reflux disease (gerd), peptic ulcer disease, zollinger–ellison syndrome, helicobacter pylori eradication (combination therapy), nsaid-induced ulcers, and others (acid-related disorders).
  • Based on the manufacturing type, the market is segmented into in-house manufacturing and contract manufacturing (CMO/CDMO).

Tablets Segment Leads the Market

The tablets segment holds a dominant position in the esomeprazole market due to its widespread adoption, affordability, and ease of administration. Tablets are commonly prescribed for GERD and ulcer treatment across healthcare systems globally. Their convenience and long shelf life make them highly preferred by patients and healthcare providers. Leading companies such as AstraZeneca and Teva Pharmaceutical Industries have expanded tablet-based product portfolios between 2022 and 2026, strengthening market presence.

Injectable (IV formulations) Segment to Record Strong Growth

The injectable segment is expected to witness strong growth due to increasing demand in hospital and emergency care settings. Injectable esomeprazole is used for severe gastrointestinal conditions requiring rapid acid suppression. Advancements in drug delivery technologies and increasing hospitalization rates are supporting segment growth. Companies are investing in formulation innovation and expanding production capacity.

Regional Outlook

The global Esomeprazole market is geographically segmented into North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa and Latin America).

United States Leads the Market

The United States dominates the esomeprazole market due to strong healthcare infrastructure and high pharmaceutical consumption. According to the Centers for Disease Control and Prevention, gastrointestinal disorders contribute significantly to healthcare visits annually. Strong regulatory frameworks and widespread availability of medications support market growth.

India to Record Strong Growth

India is expected to witness strong growth due to expanding pharmaceutical manufacturing and increasing healthcare access. According to the World Health Organization, improving healthcare infrastructure is increasing treatment adoption. Strong generics production and export capabilities further support market expansion.

Competitive Landscape

The esomeprazole market is highly competitive, with major players focusing on generic drug expansion, cost optimization, and supply chain strengthening. Leading companies such as AstraZeneca, Sandoz, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, and Sun Pharmaceutical Industries dominate the market through strong product portfolios and global distribution networks. Companies are investing in formulation innovation and expanding manufacturing capabilities to maintain competitive advantage.

Recent Developments

  • In March 2026, Sun Pharmaceutical Industries announced the launch of its semaglutide injection under the brand names Noveltreat and Sematrinity in India, offering multiple dosage strengths for chronic weight management and type 2 diabetes treatment, thereby enhancing affordability and expanding its presence in the metabolic therapeutics segment.
  • In March 2026, Sandoz announced the launch of its azelastine and fluticasone fixed-dose combination nasal spray in Germany and Switzerland, expanding access to affordable, high-quality allergy treatment options and strengthening its respiratory portfolio in European markets.

The Report Covers

  • Market value data analysis of 2025 and forecast to 2035.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global Esomeprazole market. Based on the availability of data, information related to new products and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.
  1. Report Summary
  • Current Industry Analysis and Growth Potential Outlook
  • Global Esomeprazole Market Analysis – Product Type | Application | Manufacturing Type ($ Million)
  • Esomeprazole Market Sales Performance of Top Countries
    • Research Methodology
  • Primary Research Approach
  • Secondary Research Approach

1.2 Market Snapshot

  1. Market Overview and Insights
    2.1 Scope of the Study
    2.2 Analyst Insight & Current Market Trends
    2.2.1 Key Esomeprazole Market Trends
    2.2.2 Market Recommendations

2.3 Porter's Five Forces Analysis for the Esomeprazole Market
2.3.1 Competitive Rivalry
2.3.2 Threat of New Entrants
2.3.3 Bargaining Power of Suppliers
2.3.4 Bargaining Power of Buyers
2.3.5 Threat of Substitutes

  1. Market Determinants
    3.1 Market Drivers
    3.1.1 Drivers For Global Esomeprazole Market: Impact Analysis

3.2 Market Pain Points and Challenges
3.2.1 Restraints For Global Esomeprazole Market: Impact Analysis

3.3 Market Opportunities
3.3.1 Opportunities For Global Esomeprazole Market: Impact Analysis

  1. Competitive Landscape
    4.1 Competitive Dashboard – Esomeprazole Market Revenue and Share by Manufacturers
  • Esomeprazole Product Comparison Analysis
  • Top Market Player Ranking Matrix

4.2 Key Company Analysis
4.2.1 AstraZeneca

4.2.1.1 Overview

4.2.1.2 Product Portfolio

4.2.1.3 Financial Analysis

4.2.1.4 SWOT Analysis

4.2.1.5 Business Strategy

4.2.2 Sandoz

4.2.2.1 Overview

4.2.2.2 Product Portfolio

4.2.2.3 Financial Analysis

4.2.2.4 SWOT Analysis

4.2.2.5 Business Strategy

4.2.3 Teva Pharmaceutical Industries

4.2.3.1 Overview

4.2.3.2 Product Portfolio

4.2.3.3 Financial Analysis

4.2.3.4 SWOT Analysis

4.2.3.5 Business Strategy

4.2.4 Dr Reddy's Laboratories

4.2.4.1 Overview

4.2.4.2 Product Portfolio

4.2.4.3 Financial Analysis

4.2.4.4 SWOT Analysis

4.2.4.5 Business Strategy

4.2.5 Sun Pharmaceutical Industries

4.2.5.1 Overview

4.2.5.2 Product Portfolio

4.2.5.3 Financial Analysis

4.2.5.4 SWOT Analysis

4.2.5.5 Business Strategy

4.3 Top Winning Strategies by Market Players

4.3.1 Merger and Acquisition

4.3.2 Product Launch

4.3.3 Partnership And Collaboration

  1. Global Esomeprazole Market Sales Analysis by Product Type ($ Million)

5.1 Tablets
5.2 Capsules
5.3 Injectable (IV formulations)
5.4 Oral Suspension / Sachets

  1. Global Esomeprazole Market Sales Analysis by Application ($ Million)
    6.1 Gastroesophageal Reflux Disease (GERD)
    6.2 Peptic Ulcer Disease
    6.3 Zollinger–Ellison Syndrome
    6.4 Helicobacter pylori Eradication (Combination Therapy)
    6.5 NSAID-Induced Ulcers
    6.6 Others (Acid-related disorders)
  2. Global Esomeprazole Market Sales Analysis by Manufacturing Type ($ Million)
    7.1 In-house Manufacturing
    7.2 Contract Manufacturing (CMO/CDMO)
  1. Regional Analysis

8.1 North American Esomeprazole Market Sales Analysis – Product Type | Application | Manufacturing Type ($ Million)
8.1.1 United States
8.1.2 Canada

8.2 European Esomeprazole Market Sales Analysis – Product Type | Application | Manufacturing Type ($ Million)
8.2.1 UK
8.2.2 Germany
8.2.3 Italy
8.2.4 Spain
8.2.5 France
8.2.6 Russia
8.2.7 Rest of Europe

8.3 Asia-Pacific Esomeprazole Market Sales Analysis – Product Type | Application | Manufacturing Type ($ Million)
8.3.1 China

8.3.2 Japan
8.3.3 South Korea
8.3.4 India
8.3.5 Australia & New Zealand
8.3.6 ASEAN Countries
8.3.7 Rest of Asia-Pacific

8.4 Rest of the World Esomeprazole Market Sales Analysis – Product Type | Application | Manufacturing Type ($ Million)

8.4.1 Latin America
8.4.2 Middle East and Africa

  1. Company Profiles

9.1 Aurobindo Pharma
9.1.1 Quick Facts
9.1.2 Company Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies

9.2 Cipla Ltd.
9.2.1 Quick Facts
9.2.2 Company Overview

9.2.3 Product Portfolio

9.2.4 Business Strategies

9.3 Amneal Pharmaceuticals
9.3.1 Quick Facts
9.3.2 Company Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies

9.4 Glenmark Pharmaceuticals
9.4.1 Quick Facts
9.4.2 Company Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies

9.5 Accord Healthcare
9.5.1 Quick Facts
9.5.2 Company Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies

9.6 Lupin Limited
9.6.1 Quick Facts
9.6.2 Company Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies

9.7 Zydus Lifesciences
9.7.1 Quick Facts
9.7.2 Company Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies

9.8 Hikma Pharmaceuticals
9.8.1 Quick Facts
9.8.2 Company Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies

9.9 Apotex Inc.
9.9.1 Quick Facts
9.9.2 Company Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies

9.10 Viatris
9.10.1 Quick Facts
9.10.2 Company Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies

9.11 Torrent Pharmaceuticals
9.11.1 Quick Facts
9.11.2 Company Overview

9.11.3 Product Portfolio
9.11.4 Business Strategies

9.12 Hetero Labs
9.12.1 Quick Facts
9.12.2 Company Overview
9.12.3 Product Portfolio
9.12.4 Business Strategies

9.13 Wockhardt
9.13.1 Quick Facts
9.13.2 Company Overview
9.13.3 Product Portfolio
9.13.4 Business Strategies

9.14 Alkem Laboratories
9.14.1 Quick Facts

9.14.2 Company Overview
9.14.3 Product Portfolio
9.14.4 Business Strategies

9.15 Normon
9.15.1 Quick Facts
9.15.2 Company Overview
9.15.3 Product Portfolio
9.15.4 Business Strategies

9.16 Fresenius Kabi
9.16.1 Quick Facts
9.16.2 Company Overview
9.16.3 Product Portfolio
9.16.4 Business Strategies

9.17 KRKA
9.17.1 Quick Facts
9.17.2 Company Overview
9.17.3 Product Portfolio
9.17.4 Business Strategies

9.18 STADA Arzneimittel
9.18.1 Quick Facts

9.18.2 Company Overview

9.18.3 Product Portfolio
9.18.4 Business Strategies

9.19 Alembic Pharmaceuticals
9.19.1 Quick Facts
9.19.2 Company Overview
9.19.3 Product Portfolio
9.19.4 Business Strategies

9.20 Macleods Pharmaceuticals
9.20.1 Quick Facts
9.20.2 Company Overview

9.20.3 Product Portfolio

9.20.4 Business Strategies

1. Global Esomeprazole Market Research and Analysis by Product Type, 2025–2035 ($ Million) 

2. Global Tablets Esomeprazole Market Research and Analysis by Region, 2025–2035 ($ Million) 

3. Global Capsules Esomeprazole Market Research and Analysis by Region, 2025–2035 ($ Million) 

4. Global Injectable (IV formulations) Esomeprazole Market Research and Analysis by Region, 2025–2035 ($ Million) 

5. Global Oral Suspension / Sachets Esomeprazole Market Research and Analysis by Region, 2025–2035 ($ Million) 

6. Global Esomeprazole Market Research and Analysis by Application, 2025–2035 ($ Million) 

7. Global Esomeprazole for Gastroesophageal Reflux Disease (GERD) Market Research and Analysis by Region, 2025–2035 ($ Million) 

8. Global Esomeprazole for Peptic Ulcer Disease Market Research and Analysis by Region, 2025–2035 ($ Million) 

9. Global Esomeprazole for Zollinger–Ellison Syndrome Market Research and Analysis by Region, 2025–2035 ($ Million) 

10. Global Esomeprazole for Helicobacter pylori Eradication Market Research and Analysis by Region, 2025–2035 ($ Million) 

11. Global Esomeprazole for NSAID-induced Ulcers Market Research and Analysis by Region, 2025–2035 ($ Million) 

12. Global Esomeprazole for Others (Acid-related disorders) Market Research and Analysis by Region, 2025–2035 ($ Million) 

13. Global Esomeprazole Market Research and Analysis by Manufacturing Type, 2025–2035 ($ Million) 

14. Global In-house Manufacturing Esomeprazole Market Research and Analysis by Region, 2025–2035 ($ Million) 

15. Global Contract Manufacturing (CMO/CDMO) Esomeprazole Market Research and Analysis by Region, 2025–2035 ($ Million) 

16. Global Esomeprazole Market Research and Analysis by Region, 2025–2035 ($ Million) 

17. North America Esomeprazole Market Research and Analysis by Country, 2025–2035 ($ Million) 

18. North America Esomeprazole Market Research and Analysis by Product Type, 2025–2035 ($ Million) 

19. North America Esomeprazole Market Research and Analysis by Application, 2025–2035 ($ Million) 

20. North America Esomeprazole Market Research and Analysis by Manufacturing Type, 2025–2035 ($ Million) 

21. Europe Esomeprazole Market Research and Analysis by Country, 2025–2035 ($ Million) 

22. Europe Esomeprazole Market Research and Analysis by Product Type, 2025–2035 ($ Million) 

23. Europe Esomeprazole Market Research and Analysis by Application, 2025–2035 ($ Million) 

24. Europe Esomeprazole Market Research and Analysis by Manufacturing Type, 2025–2035 ($ Million) 

25. Asia-Pacific Esomeprazole Market Research and Analysis by Country, 2025–2035 ($ Million) 

26. Asia-Pacific Esomeprazole Market Research and Analysis by Product Type, 2025–2035 ($ Million) 

27. Asia-Pacific Esomeprazole Market Research and Analysis by Application, 2025–2035 ($ Million) 

28. Asia-Pacific Esomeprazole Market Research and Analysis by Manufacturing Type, 2025–2035 ($ Million) 

29. Rest of the World Esomeprazole Market Research and Analysis by Region, 2025–2035 ($ Million) 

30. Rest of the World Esomeprazole Market Research and Analysis by Product Type, 2025–2035 ($ Million) 

31. Rest of the World Esomeprazole Market Research and Analysis by Application, 2025–2035 ($ Million) 

32. Rest of the World Esomeprazole Market Research and Analysis by Manufacturing Type, 2025–2035 ($ Million) 

1. Global Esomeprazole Market Share by Product Type, 2025 Vs 2035 (%) 

2. Global Tablets Esomeprazole Market Share by Region, 2025 Vs 2035 (%) 

3. Global Capsules Esomeprazole Market Share by Region, 2025 Vs 2035 (%) 

4. Global Injectable (IV formulations) Esomeprazole Market Share by Region, 2025 Vs 2035 (%) 

5. Global Oral Suspension / Sachets Esomeprazole Market Share by Region, 2025 Vs 2035 (%) 

6. Global Esomeprazole Market Share by Application, 2025 Vs 2035 (%) 

7. Global Esomeprazole for Gastroesophageal Reflux Disease (GERD) Market Share by Region, 2025 Vs 2035 (%) 

8. Global Esomeprazole for Peptic Ulcer Disease Market Share by Region, 2025 Vs 2035 (%) 

9. Global Esomeprazole for Zollinger–Ellison Syndrome Market Share by Region, 2025 Vs 2035 (%) 

10. Global Esomeprazole for Helicobacter pylori Eradication Market Share by Region, 2025 Vs 2035 (%) 

11. Global Esomeprazole for NSAID-induced Ulcers Market Share by Region, 2025 Vs 2035 (%) 

12. Global Esomeprazole for Others (Acid-related disorders) Market Share by Region, 2025 Vs 2035 (%) 

13. Global Esomeprazole Market Share by Manufacturing Type, 2025 Vs 2035 (%) 

14. Global In-house Manufacturing Esomeprazole Market Share by Region, 2025 Vs 2035 (%) 

15. Global Contract Manufacturing (CMO/CDMO) Esomeprazole Market Share by Region, 2025 Vs 2035 (%) 

16. Global Esomeprazole Market Share by Region, 2025 Vs 2035 (%) 

17. US Esomeprazole Market Size, 2025–2035 ($ Million) 

18. Canada Esomeprazole Market Size, 2025–2035 ($ Million) 

19. UK Esomeprazole Market Size, 2025–2035 ($ Million) 

20. France Esomeprazole Market Size, 2025–2035 ($ Million) 

21. Germany Esomeprazole Market Size, 2025–2035 ($ Million) 

22. Italy Esomeprazole Market Size, 2025–2035 ($ Million) 

23. Spain Esomeprazole Market Size, 2025–2035 ($ Million) 

24. Russia Esomeprazole Market Size, 2025–2035 ($ Million) 

25. India Esomeprazole Market Size, 2025–2035 ($ Million) 

26. China Esomeprazole Market Size, 2025–2035 ($ Million) 

27. Japan Esomeprazole Market Size, 2025–2035 ($ Million) 

28. South Korea Esomeprazole Market Size, 2025–2035 ($ Million) 

29. Australia & New Zealand Esomeprazole Market Size, 2025–2035 ($ Million) 

30. ASEAN Esomeprazole Market Size, 2025–2035 ($ Million) 

31. Rest of Asia-Pacific Esomeprazole Market Size, 2025–2035 ($ Million) 

32. Latin America Esomeprazole Market Size, 2025–2035 ($ Million) 

33. Middle East & Africa Esomeprazole Market Size, 2025–2035 ($ Million)

Choose License Type
    On Discount
Enterprise Custom
  • Printable version
  • No restriction to number of users within the company
CONTACT SALES

100%
Secured Payment

Why buy from us?
  • Covers more than 15 major industries, which are further segmented into 90+ sectors
  • 65% of our clients are loyal customers
  • 120+ countries are covered in analysis
  • currently servicing 1000+ customers globally
  • 100+ paid data sources mined to research
  • Our expert team will assist you with all research need and customization
  • Our expert research analyst will resolve your every query before and after purchasing the report
Related Reports

FAQS

The size of the Esomeprazole Market in 2025 is estimated to be around $2.01 billion.
United States holds the largest share in the Esomeprazole Market.
Leading players in the Esomeprazole Market Includes AstraZeneca, Sandoz, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, and Sun Pharmaceutical Industries., among others.
The Esomeprazole Market is expected to grow at a CAGR of 6.05% from 2026 to 2035.
Increasing prevalence of gastrointestinal disorders, growing awareness about acid reflux and ulcer treatments, and rising demand for proton pump inhibitor medications are driving the Esomeprazole Market growth.